phenylacetic acid has been researched along with Disease Models, Animal in 8 studies
phenylacetic acid : A monocarboxylic acid that is toluene in which one of the hydrogens of the methyl group has been replaced by a carboxy group.
Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Paraoxonase activity has been reported to decrease in several situations associated with atherosclerosis and oxidative stress." | 5.34 | High-dose taurine supplementation increases serum paraoxonase and arylesterase activities in experimental hypothyroidism. ( Dirican, M; Sarandöl, E; Taş, S, 2007) |
| " Anticonvulsant activity was tested against clonic seizures induced by pentylenetetrazole (PTZ, 60 mg/kg, i." | 3.85 | In silico Screening and Evaluation of the Anticonvulsant Activity of Docosahexaenoic Acid-Like Molecules in Experimental Models of Seizures. ( Gharibi Loron, A; Narenjkar, J; Sardari, S; Sayyah, M, 2017) |
| "Ornithine phenylacetate (OP) is a new drug that has been proposed for the treatment of hepatic encephalopathy (HE) because it decreases plasma ammonia." | 3.78 | Ornithine phenylacetate prevents disturbances of motor-evoked potentials induced by intestinal blood in rats with portacaval anastomosis. ( Arranz, JA; Córdoba, J; Oria, M; Raguer, N; Riudor, E; Romero-Giménez, J, 2012) |
| "Paraoxonase activity has been reported to decrease in several situations associated with atherosclerosis and oxidative stress." | 1.34 | High-dose taurine supplementation increases serum paraoxonase and arylesterase activities in experimental hypothyroidism. ( Dirican, M; Sarandöl, E; Taş, S, 2007) |
| "Leptin treatment had no effect on plasma lipid profile and glucose level." | 1.32 | Leptin decreases plasma paraoxonase 1 (PON1) activity and induces oxidative stress: the possible novel mechanism for proatherogenic effect of chronic hyperleptinemia. ( Bełtowski, J; Jamroz, A; Wójcicka, G, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, RPM | 1 |
| Yasgar, A | 1 |
| Teramoto, T | 1 |
| Lee, MH | 1 |
| Dorjsuren, D | 1 |
| Eastman, RT | 1 |
| Malik, N | 1 |
| Zakharov, AV | 1 |
| Li, W | 1 |
| Bachani, M | 1 |
| Brimacombe, K | 1 |
| Steiner, JP | 1 |
| Hall, MD | 1 |
| Balasubramanian, A | 1 |
| Jadhav, A | 1 |
| Padmanabhan, R | 1 |
| Simeonov, A | 1 |
| Nath, A | 1 |
| Pribytkova, T | 1 |
| Lightly, TJ | 1 |
| Kumar, B | 1 |
| Bernier, SP | 1 |
| Sorensen, JL | 1 |
| Surette, MG | 1 |
| Cardona, ST | 1 |
| Gharibi Loron, A | 1 |
| Sardari, S | 1 |
| Narenjkar, J | 1 |
| Sayyah, M | 1 |
| Oria, M | 1 |
| Romero-Giménez, J | 1 |
| Arranz, JA | 1 |
| Riudor, E | 1 |
| Raguer, N | 1 |
| Córdoba, J | 1 |
| Bełtowski, J | 1 |
| Wójcicka, G | 1 |
| Jamroz, A | 1 |
| Dirican, M | 1 |
| Taş, S | 1 |
| Sarandöl, E | 1 |
| Sarkissian, CN | 1 |
| Scriver, CR | 1 |
| Mamer, OA | 1 |
| Loo, YH | 1 |
| Potempska, A | 1 |
| Wisniewski, HM | 1 |
8 other studies available for phenylacetic acid and Disease Models, Animal
| Article | Year |
|---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Dr | 2020 |
The attenuated virulence of a Burkholderia cenocepacia paaABCDE mutant is due to inhibition of quorum sensing by release of phenylacetic acid.
Topics: Acyl-Butyrolactones; Animals; Bacterial Proteins; Burkholderia cenocepacia; Burkholderia Infections; | 2014 |
In silico Screening and Evaluation of the Anticonvulsant Activity of Docosahexaenoic Acid-Like Molecules in Experimental Models of Seizures.
Topics: Animals; Anticonvulsants; Disease Models, Animal; Docosahexaenoic Acids; Drug Design; Electroshock; | 2017 |
Ornithine phenylacetate prevents disturbances of motor-evoked potentials induced by intestinal blood in rats with portacaval anastomosis.
Topics: Amino Acids; Ammonia; Animals; Brain; Disease Models, Animal; Evoked Potentials, Motor; Glutamine; H | 2012 |
Leptin decreases plasma paraoxonase 1 (PON1) activity and induces oxidative stress: the possible novel mechanism for proatherogenic effect of chronic hyperleptinemia.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Animals; Antimetabolites, Antineoplastic; Antioxidan | 2003 |
High-dose taurine supplementation increases serum paraoxonase and arylesterase activities in experimental hypothyroidism.
Topics: Animals; Antioxidants; Aryldialkylphosphatase; Carboxylic Ester Hydrolases; Cholesterol; Cholesterol | 2007 |
Measurement of phenyllactate, phenylacetate, and phenylpyruvate by negative ion chemical ionization-gas chromatography/mass spectrometry in brain of mouse genetic models of phenylketonuria and non-phenylketonuria hyperphenylalaninemia.
Topics: Animals; Brain; Disease Models, Animal; Gas Chromatography-Mass Spectrometry; Humans; Lactates; Mice | 2000 |
A biochemical explanation of phenyl acetate neurotoxicity in experimental phenylketonuria.
Topics: 3-Hydroxybutyric Acid; Acetyl Coenzyme A; Animals; Brain; Disease Models, Animal; Female; Glycoprote | 1985 |